Overview

Controlled Study of MK-0431/ONO-5435 in Patients With Type 2 Diabetes Mellitus

Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
0
Participant gender:
All
Summary
The purpose of this study is to determine the safety and efficacy of MK-0431/ONO-5435 in patients with Type 2 diabetes mellitus who have inadequate glycemic control on diet/exercise therapy and metformin as monotherapy
Phase:
Phase 3
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Ono Pharmaceutical Co. Ltd
Treatments:
Sitagliptin Phosphate
Criteria
Inclusion Criteria:

- Patients with type 2 diabetes mellitus on diet/exercise therapy and metformin as
monotherapy

Exclusion Criteria:

- Patients with type 1 diabetes mellitus